Clinical trial
Prognostic Value of [¹⁷⁷Lu]Lu-PSMA SPECT and Timing of RECIP Assessment in mCRPC
NCT07643935 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of [¹⁷⁷Lu]Lu-PSMA SPECT and Timing of RECIP Assessment in mCRPC
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- July 1, 2026
- Completion date
- December 1, 2026
- Enrollment
- 280 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
therapy-associated cancer